Literature DB >> 23441100

Using genetic proxies for lifecourse sun exposure to assess the causal relationship of sun exposure with circulating vitamin d and prostate cancer risk.

Carolina Bonilla1, Rebecca Gilbert, John P Kemp, Nicholas J Timpson, David M Evans, Jenny L Donovan, Freddie C Hamdy, David E Neal, William D Fraser, Smith George Davey, Sarah J Lewis, Mark Lathrop, Richard M Martin.   

Abstract

BACKGROUND: Ecological and epidemiological studies have identified an inverse association of intensity and duration of sunlight exposure with prostate cancer, which may be explained by a reduction in vitamin D synthesis. Pigmentation traits influence sun exposure and therefore may affect prostate cancer risk. Because observational studies are vulnerable to confounding and measurement error, we used Mendelian randomization to examine the relationship of sun exposure with both prostate cancer risk and the intermediate phenotype, plasma levels of vitamin D.
METHODS: We created a tanning, a skin color, and a freckling score as combinations of single nucleotide polymorphisms that have been previously associated with these phenotypes. A higher score indicates propensity to burn, have a lighter skin color and freckles. The scores were tested for association with vitamin D levels (25-hydroxyvitamin-D and 1,25-dihydroxyvitamin-D) and prostate-specific antigen detected prostate cancer in 3,123 White British individuals enrolled in the Prostate Testing for cancer and Treatment (ProtecT) study.
RESULTS: The freckling score was inversely associated with 25(OH)D levels [change in 25(OH)D per score unit -0.27; 95% CI, -0.52% to -0.01%], and the tanning score was positively associated with prostate cancer risk (OR = 1.05; 95% CI, 1.02-1.09), after adjustment for population stratification and potential confounders.
CONCLUSIONS: Individuals who tend to burn are more likely to spend less time in the sun and consequently have lower plasma vitamin D levels and higher susceptibility to prostate cancer. IMPACT: The use of pigmentation-related genetic scores is valuable for the assessment of the potential benefits of sun exposure with respect to prostate cancer risk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23441100      PMCID: PMC3616836          DOI: 10.1158/1055-9965.EPI-12-1248

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  37 in total

1.  Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer.

Authors:  C J Luscombe; A A Fryer; M E French; S Liu; M F Saxby; P W Jones; R C Strange
Journal:  Lancet       Date:  2001-08-25       Impact factor: 79.321

2.  Human skin pigmentation, migration and disease susceptibility.

Authors:  Nina G Jablonski; George Chaplin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

3.  Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis.

Authors:  Rebecca Gilbert; Chris Metcalfe; Steven E Oliver; David C Whiteman; Chris Bain; Andy Ness; Jenny Donovan; Freddie Hamdy; David E Neal; J Athene Lane; Richard M Martin
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

4.  Association of 25-hydroxyvitamin D3)levels in adult New Zealanders with ethnicity, skin color and self-reported skin sensitivity to sun exposure.

Authors:  Sofia Nessvi; Lisa Johansson; Jan Jopson; Alistair Stewart; Anthony Reeder; Richard McKenzie; Robert K Scragg
Journal:  Photochem Photobiol       Date:  2011-07-28       Impact factor: 3.421

5.  The validity and practicality of sun-reactive skin types I through VI.

Authors:  T B Fitzpatrick
Journal:  Arch Dermatol       Date:  1988-06

6.  Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.

Authors:  Rebecca Gilbert; Chris Metcalfe; William D Fraser; Jenny Donovan; Freddie Hamdy; David E Neal; J Athene Lane; Richard M Martin
Journal:  Int J Cancer       Date:  2011-12-21       Impact factor: 7.396

7.  Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer.

Authors:  W D Fraser; B H Durham; J L Berry; E B Mawer
Journal:  Ann Clin Biochem       Date:  1997-11       Impact factor: 2.057

8.  Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase.

Authors:  Jeffrey B Cheng; Michael A Levine; Norman H Bell; David J Mangelsdorf; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

9.  Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.

Authors:  Debbie A Lawlor; Roger M Harbord; Jonathan A C Sterne; Nic Timpson; George Davey Smith
Journal:  Stat Med       Date:  2008-04-15       Impact factor: 2.373

10.  Evaluation of genetic markers as instruments for Mendelian randomization studies on vitamin D.

Authors:  Diane J Berry; Karani S Vimaleswaran; John C Whittaker; Aroon D Hingorani; Elina Hyppönen
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240

View more
  16 in total

Review 1.  Adding Mendelian randomization to a meta-analysis-a burgeoning opportunity.

Authors:  Wenquan Niu; Mingliang Gu
Journal:  Tumour Biol       Date:  2015-12-22

2.  Polymorphisms in vitamin D-related genes and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Edward A Ruiz-Narváez; Stephen A Haddad; Lynn Rosenberg; Julie R Palmer
Journal:  Fertil Steril       Date:  2014-06-02       Impact factor: 7.329

3.  Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.

Authors:  Freddie C Hamdy; Jenny L Donovan; J Athene Lane; Malcolm Mason; Chris Metcalfe; Peter Holding; Julia Wade; Sian Noble; Kirsty Garfield; Grace Young; Michael Davis; Tim J Peters; Emma L Turner; Richard M Martin; Jon Oxley; Mary Robinson; John Staffurth; Eleanor Walsh; Jane Blazeby; Richard Bryant; Prasad Bollina; James Catto; Andrew Doble; Alan Doherty; David Gillatt; Vincent Gnanapragasam; Owen Hughes; Roger Kockelbergh; Howard Kynaston; Alan Paul; Edgar Paez; Philip Powell; Stephen Prescott; Derek Rosario; Edward Rowe; David Neal
Journal:  Health Technol Assess       Date:  2020-08       Impact factor: 4.014

4.  Mendelian randomization studies of cancer risk: a literature review.

Authors:  Brandon L Pierce; Peter Kraft; Chenan Zhang
Journal:  Curr Epidemiol Rep       Date:  2018-05-18

5.  Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy.

Authors:  Rebecca Gilbert; Richard M Martin; David M Evans; Kate Tilling; George Davey Smith; John P Kemp; J Athene Lane; Freddie C Hamdy; David E Neal; Jenny L Donovan; Chris Metcalfe
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

6.  Skin pigmentation, sun exposure and vitamin D levels in children of the Avon Longitudinal Study of Parents and Children.

Authors:  Carolina Bonilla; Andrew R Ness; Andrew K Wills; Debbie A Lawlor; Sarah J Lewis; George Davey Smith
Journal:  BMC Public Health       Date:  2014-06-12       Impact factor: 3.295

7.  Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels.

Authors:  Visalini Nair-Shalliker; Sam Egger; Agata Chrzanowska; Rebecca Mason; Louise Waite; David Le Couteur; Markus J Seibel; David J Handelsman; Robert Cumming; David P Smith; Bruce K Armstrong
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

8.  Identification of low oxygen-tolerating bacteria in prostate secretions of cancer patients and discussion of possible aetiological significance.

Authors:  Roshni Bhudia; Amar Ahmad; Onyinye Akpenyi; Angela Whiley; Mark Wilks; Tim Oliver
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

9.  Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.

Authors:  Rebecca Gilbert; Carolina Bonilla; Chris Metcalfe; Sarah Lewis; David M Evans; William D Fraser; John P Kemp; Jenny L Donovan; Freddie C Hamdy; David E Neal; J Athene Lane; George Davey Smith; Mark Lathrop; Richard M Martin
Journal:  Cancer Causes Control       Date:  2014-12-09       Impact factor: 2.506

Review 10.  Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis.

Authors:  J M Rhodes; S Subramanian; E Laird; G Griffin; R A Kenny
Journal:  J Intern Med       Date:  2020-07-22       Impact factor: 13.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.